Lymphogranulomatosis venereum

Lymphogranulomatosis venereal: understanding, diagnosis and treatment

Lymphogranulomatosis venereum, also known as lymphogranulomatosis venereum or lymphogranulomatosis venerica, is a sexually transmitted infectious disease. It is caused by the bacterium Chlamydia trachomatis, which can affect the lymph nodes, skin and mucous membranes of the genitals.

A characteristic feature of lymphogranulomatosis venereum is the progressive nature of the disease. After an incubation period, which can last from several days to several weeks, primary ulcers or sores appear at the site of infection. Typically they may not be noticeable or go unnoticed, making early diagnosis of the disease difficult.

Over time, the bacterium spreads through the lymphatic vessels and affects the lymph nodes. This can lead to their enlargement, abscess formation, or even fibrosis. In addition, lymphogranulomatosis venereum can cause inflammation of the external genitalia, rectum or eyes.

Diagnosis of lymphogranulomatosis venereum is based on medical history, physical examination and laboratory tests. An important component of diagnosis is mandatory testing for other sexually transmitted infections, such as syphilis and gonorrhea, since they can accompany lymphogranulomatosis.

Treatment for lymphogranulomatosis venereum includes the use of antibiotics such as doxycycline or azithromycin. The course of treatment usually lasts for several weeks, and it is important to follow your doctor's instructions and complete the full course of treatment, even if symptoms disappear.

In addition to treatment, important aspects of managing lymphogranulomatosis venereum include preventing the spread of infection and ensuring public education about methods of protection against sexually transmitted infections. Using condoms during sexual intercourse and regularly getting screened for sexually transmitted infections are important preventive measures.

In conclusion, lymphogranulomatosis venereum is a serious infectious disease that requires timely diagnosis and adequate treatment. By taking appropriate precautions and educating the public about sexually transmitted infections, it is possible to reduce the spread of this disease. Early diagnosis, accurate treatment and preventive measures are key aspects of controlling lymphogranulomatosis venereum and reducing its spread.

Lymphoplacental heterotopic lymphomyelosis (LLGL) (also known as infectious lymphogranulomatosis) is an inflammatory disease characterized by a polymorphic clinical picture, laboratory and morphological signs of a disseminated process affecting the lymphatic vessels and nodes, as well as plasma cells in the lymph nodes (placenta) and adjacent tissues of the lymphatic system . LLGL can occur as an independent disease or together with other infectious diseases, for example, syphilis. In addition, sometimes there is no clear boundary between syphilitic purpura and Bowen's disease or other soft tissue tumors such as simple hydroma or even leukoplakia.

Case History of LLH Lymphoproliferative syndrome (LPS) is a systemic disease of the immune system characterized by the proliferation of many types of lymphocytes in the absence of autoimmune defects (coedless or X-linked agammaglobulinemia, hypergammaglobinumia, or hemolytic anemia). LPS differs from other malignant lymphomas in that there are typically no cancer cells in the periphery of the lymph node. This means doctors cannot easily pinch off a tissue sample for testing. With LPS, the disease often manifests itself in childhood. Most patients over 50 years of age have a chronic infection with Epstein-Barr virus (EBV) or chronic fatigue syndrome (CFS). "In the preclinical phase of lymphoproliferative syndrome, immunological reactions begin to come into balance with the results of repeated blood tests. The clinical diagnosis of LPSS is established when the degree of decrease in the number leukocytes are insufficient to measure the level of positive expression of EBV marker markers or CMV marker markers and when there is much doubt about the causes of inflammatory diseases of the liver or respiratory tract or bronchi of the lungs.Sometimes with LPS, mussel disease develops, which is usually considered as an abnormal condition in patients whose immune system has an abnormal response to EBV: hypogammaglutaminemia (HLH) with hypercalcemia

In acute mussel forms of the disease, in contrast to remission, there are disturbances in the expression of EBVIOVP markers. If the number of leukocytes decreases excessively, this indicates the causes of lymphoprolipathic syndrome, diagnosed after assessing symptoms and liver functions."